Rotavirus Vaccines (DBCOND0033911)

Identifiers

Synonyms
Rotavirus Vaccine / Vaccine product containing only Rotavirus antigen (medicinal product)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT02914184
Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeksprevention3completed
NCT00969228
Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infantsprevention4completed
NCT00995813
Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failureprevention4completed
NCT00480324
Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infantsprevention3completed
NCT05037435
Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years.prevention3completed
NCT00669929
Cost-Effectiveness Analysis of Rotavirus Vaccination for Children in KoreaNo drug interventionsNot AvailableNot Availableunknown_status
NCT00595205
Intussusception Surveillance After Rotarix Introduction in MexicoNo drug interventionsNot AvailableNot Availablecompleted
NCT01177826
Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized ChildrenNo drug interventionsNot AvailableNot Availablecompleted
NCT00353366
To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First VaccinationNot AvailableNot Availablecompleted
NCT01733862
Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus GastroenteritisNo drug interventionsNot AvailableNot Availablecompleted
NCT00432380
A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.prevention2completed
NCT03804489
Using "Decision Aids" to Help the Infant Family to Decide the Use of Oral Rotavirus VaccineNo drug interventionshealth_services_researchNot Availableunknown_status
NCT03207750
This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccineprevention3completed
NCT02193061
Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention Programsprevention3completed
NCT04344054
Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccinetreatment2completed